Literature DB >> 18627566

Cardiac problems in the dialysis patient: beyond coronary disease.

Andrew Remppis1, Eberhard Ritz.   

Abstract

In end-stage renal disease (ESRD) both an inappropriately high sympathetic drive and the activation of tissue-based renin-angiotensin systems lead to a complex pattern of comorbidity appearing early on in renal disease. In this context, uremic cardiomyopathy, diabetes, and renal failure display an intimate interaction that critically defines the prognosis in dialysis patients. Importantly, patients with moderate to severe loss of renal function not only carry a high burden of traditional cardiovascular risk factors, but also are exposed to uremia-specific risk factors that in concert induce an excessively increased cardiovascular mortality. Although cardiovascular guidelines may not simply be applicable to ESRD patients--these have invariably been excluded from larger cardiovascular trials--an early cardiological workup appears rational as the prevailing mode of death is characterized by sudden cardiac death and heart failure. This short review will therefore go beyond coronary heart disease, focus on the specific cardiac pathology in renal failure, and summarize the contemporary therapeutic strategies in ESRD.

Entities:  

Mesh:

Year:  2008        PMID: 18627566     DOI: 10.1111/j.1525-139X.2008.00457.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  15 in total

1.  Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure.

Authors:  Steven T Haller; David J Kennedy; Amjad Shidyak; George V Budny; Deepak Malhotra; Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Am J Hypertens       Date:  2012-03-01       Impact factor: 2.689

Review 2.  Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?

Authors:  Elzbieta Mlodawska; Paulina Lopatowska; Jolanta Malyszko; Maciej Banach; Bożena Sobkowicz; Adrian Covic; Anna Tomaszuk-Kazberuk
Journal:  Int Urol Nephrol       Date:  2018-05-21       Impact factor: 2.370

Review 3.  Antiplatelet agents for chronic kidney disease.

Authors:  Patrizia Natale; Suetonia C Palmer; Valeria M Saglimbene; Marinella Ruospo; Mona Razavian; Jonathan C Craig; Meg J Jardine; Angela C Webster; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2022-02-28

Review 4.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

5.  The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.

Authors:  Sibel Ertek; Ayse Nur Torun; Kenan Ates
Journal:  Int Urol Nephrol       Date:  2009-08-04       Impact factor: 2.370

6.  ADPKD: Prototype of Cardiorenal Syndrome Type 4.

Authors:  Grazia Maria Virzì; Valentina Corradi; Anthi Panagiotou; Fiorella Gastaldon; Dinna N Cruz; Massimo de Cal; Maurizio Clementi; Claudio Ronco
Journal:  Int J Nephrol       Date:  2010-12-21

7.  Predictors of Arrhythmic Events Detected by Implantable Loop Recorders in Renal Transplant Candidates.

Authors:  Rodrigo Tavares Silva; Martino Martinelli Filho; Giselle de Lima Peixoto; José Jayme Galvão de Lima; Sérgio Freitas de Siqueira; Roberto Costa; Luís Henrique Wolff Gowdak; Flávio Jota de Paula; Roberto Kalil Filho; José Antônio Franchini Ramires
Journal:  Arq Bras Cardiol       Date:  2015-09-04       Impact factor: 2.000

Review 8.  Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease.

Authors:  Kristen L Jablonski; Michel Chonchol
Journal:  F1000Prime Rep       Date:  2014-08-01

9.  Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease.

Authors:  Dorota Drożdż; Przemko Kwinta; Krystyna Sztefko; Zbigniew Kordon; Tomasz Drożdż; Monika Łątka; Monika Miklaszewska; Katarzyna Zachwieja; Andrzej Rudziński; Jacek Antoni Pietrzyk
Journal:  Oxid Med Cell Longev       Date:  2016-01-18       Impact factor: 6.543

10.  Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan.

Authors:  Cheng-Huang Shen; Cai-Mei Zheng; Kee-Thai Kiu; Hsin-An Chen; Chia-Chang Wu; Kuo-Cheng Lu; Yung-Ho Hsu; Yuh-Feng Lin; Yuan-Hung Wang
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.